Infection in humans and animals caused by fungi in the class Zygomycetes. It includes MUCORMYCOSIS and entomophthoramycosis. The latter is a tropical infection of subcutaneous tissue or paranasal sinuses caused by fungi in the order Entomophthorales. Phycomycosis, closely related to zygomycosis, describes infection with members of Phycomycetes, an obsolete classification.
Infection in humans and animals caused by any fungus in the order Mucorales (e.g., Absidia, Mucor, Rhizopus etc.) There are many clinical types associated with infection of the central nervous system, lung, gastrointestinal tract, skin, orbit and paranasal sinuses. In humans, it usually occurs as an opportunistic infection in patients with a chronic debilitating disease, particularly uncontrolled diabetes, or who are receiving immunosuppressive agents. (From Dorland, 28th ed)
A genus of zygomycetous fungi of the family Mucoraceae, order MUCORALES, a common saprophyte and facultative parasite of mature fruits and vegetables. It may cause cerebral mycoses in diabetes and cutaneous infection in severely burned patients.
An order of zygomycetous fungi, usually saprophytic, causing damage to food in storage, but which may cause respiratory infection or MUCORMYCOSIS in persons suffering from other debilitating diseases.
A genus of zygomycetous fungi, family Mucoraceae, order MUCORALES, which sometimes causes infection in humans.
A genus of zygomycetous fungi of the family Mucoraceae, order MUCORALES.
Superficial infections of the skin or its appendages by any of various fungi.
An order of fungi comprising mostly insect pathogens, though some infect mammals including humans. Strict host specificity make these fungi a focus of many biological control studies.
Disorders of the nose, general or unspecified.
A genus of fungi in the family Ancylistaceae, order ENTOMOPHTHORALES, characterized by the presence of small nuclei with a prominent central nucleolus in interphase. They are commonly found in the soil but also infect termites, aphids, and sometimes, though rarely, mammals including humans. (Alexopoulos et al, Introductory Mycology, 4th ed, pp159-60)
A genus of zygomycetous fungi of the family Mucoraceae, order Mucorales. It is primarily saprophytic, but may cause MUCORMYCOSIS in man from spores germinating in the lungs.
Diseases of the bony orbit and contents except the eyeball.
Macrolide antifungal antibiotic produced by Streptomyces nodosus obtained from soil of the Orinoco river region of Venezuela.
Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues.
Diseases affecting or involving the PARANASAL SINUSES and generally manifesting as inflammation, abscesses, cysts, or tumors.
Pulmonary diseases caused by fungal infections, usually through hematogenous spread.
A human or animal whose immunologic mechanism is deficient because of an immunodeficiency disorder or other disease or as the result of the administration of immunosuppressive drugs or radiation.
A kingdom of eukaryotic, heterotrophic organisms that live parasitically as saprobes, including MUSHROOMS; YEASTS; smuts, molds, etc. They reproduce either sexually or asexually, and have life cycles that range from simple to complex. Filamentous fungi, commonly known as molds, refer to those that grow as multicellular colonies.
Triazoles are a class of antifungal drugs that contain a triazole ring in their chemical structure and work by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting the integrity and function of the membrane.
A genus of fungi in the family Entomophthoraceae, order Entomorphthorales. They are primarily parasites of insects and spiders, but have been found to cause mycotic infections of the nose in man and horses.
The small ribonucleoprotein component of RIBOSOMES. It contains the MESSENGER RNA binding site and two TRANSFER RNA binding sites - one for the incoming AMINO ACYL TRNA (A site) and the other (P site) for the peptidyl tRNA carrying the elongating peptide chain.
Infections of the respiratory tract with fungi of the genus ASPERGILLUS. Infections may result in allergic reaction (ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS), colonization in pulmonary cavities as fungus balls (MYCETOMA), or lead to invasion of the lung parenchyma (INVASIVE PULMONARY ASPERGILLOSIS).
A life-threatening complication of diabetes mellitus, primarily of TYPE 1 DIABETES MELLITUS with severe INSULIN deficiency and extreme HYPERGLYCEMIA. It is characterized by KETOSIS; DEHYDRATION; and depressed consciousness leading to COMA.
A genus of zygomycetous fungi of the family Cunninghamellaceae, order MUCORALES. Some species cause systemic infections in humans.
An infection caused by an organism which becomes pathogenic under certain conditions, e.g., during immunosuppression.

Epidemiology of visceral mycoses: analysis of data in annual of the pathological autopsy cases in Japan. (1/105)

The data on visceral mycoses that had been reported in the Annual of the Pathological Autopsy Cases in Japan from 1969 to 1994 by the Japanese Society of Pathology were analyzed epidemiologically. The frequency of visceral mycoses among the annual total number of pathological autopsy cases increased noticeably from 1.60% in 1969 to a peak of 4.66% in 1990. Among them, the incidences of candidiasis and aspergillosis increased the most. After 1990, however, the frequency of visceral mycoses decreased gradually. Until 1989, the predominant causative agent was Candida, followed in order by Aspergillus and Cryptococcus. Although the rate of candidiasis decreased by degrees from 1990, the rate of aspergillosis increased up to and then surpassed that of candidiasis in 1991. Leukemia was the major disease underlying the visceral mycoses, followed by solid cancers and other blood and hematopoietic system diseases. Severe mycotic infection has increased over the reported 25-year period, from 6.6% of the total visceral mycosis cases in 1969 to 71% in 1994. The reasons for this decrease of candidiasis combined with an increase of aspergillosis or of severe mycotic infection might be that (i) nonsevere (not disseminated) infections were excluded from the case totals, since they have become controllable by antifungal drugs such as fluconazole, but (ii) the available antifungal drugs were not efficacious against severe infections such as pulmonary aspergillosis, and (iii) the number of patients living longer in an immunocompromised state had increased because of developments in chemotherapy and progress in medical care.  (+info)

Disseminated zygomycosis due to Rhizopus schipperae after heatstroke. (2/105)

A 21-year-old woman suffered heatstroke and developed diarrhea while trekking across south Texas. The heatstroke was complicated by seizures, rhabdomyolysis, pneumonia, renal failure, and disseminated intravascular coagulation. The patient's stool and blood cultures grew Campylobacter jejuni. The patient subsequently developed paranasal and gastrointestinal zygomycosis and required surgical debridement and a prolonged course of amphotericin B. The zygomycete cultured was Rhizopus schipperae. This is only the second isolate of R. schipperae that has been described. R. schipperae is characterized by the production of clusters of up to 10 sporangiophores arising from simple but well-developed rhizoids. These asexual reproductive propagules are produced on Czapek Dox agar but are absent on routine mycology media, where only chlamydospores are observed. Despite multiorgan failure, bacteremia, and disseminated zygomycosis, the patient survived and had a good neurological outcome. Heatstroke has not been previously described as a risk factor for the development of disseminated zygomycosis.  (+info)

Gastrointestinal zygomycotic infection caused by Basidiobolus ranarum: case report and review. (3/105)

Basidiobolus species are filamentous fungi belonging to the order Entomophthorales. Unlike other zygomycetes, Basidiobolus species have been mainly associated with a tropical form of subcutaneous zygomycosis in otherwise healthy individuals. Visceral disease caused by this pathogen is rare, but cases of gastrointestinal infection with Basidiobolus ranarum have been reported worldwide. In many of these reports, the inflammatory disease of the colon has been confused with Crohn's disease. We report the third case of B. ranarum gastrointestinal infection in the United States, which was initially treated as inflammatory bowel disease.  (+info)

Renal zygomycosis: an under-diagnosed cause of acute renal failure. (4/105)

BACKGROUND: Invasive zygomycosis (mucormycosis) occurs predominantly in immunocompromised patients in whom it carries a grave prognosis. While renal involvement is not so uncommon in disseminated infection, isolated renal zygomycosis is rare. METHODS AND RESULTS: Forty-five patients with systemic zygomycosis were seen over a 12-year period from January 1986 to December 1997. Among these, 18 had renal involvement, nine with disseminated disease and nine with isolated renal zygomycosis. No underlying predisposing disease was identified in the majority of patients (72%). Renal involvement was confirmed at autopsy in 13 and by ante-mortem renal biopsy in five patients. The infection involved one kidney in five patients and was bilateral in the remaining. The manifestations included fever, flank pain, haematuria and pyuria with evidence of enlarged non-functioning kidneys on computerised tomography (CT). Of those with bilateral disease, 12 (92.3%) had anuric acute renal failure. Anti-fungal therapy was given to six patients (amphotericin B in mean total dose of 1.1 g) and of these only two with unilateral disease who also underwent nephrectomy survived while all the other 16 died. CONCLUSION: This study shows that renal zygomycosis has emerged as a cause of acute renal failure in the last decade since no patient with renal involvement was identified at our centre prior to 1986 even though autopsies have been done regularly in patients dying of unknown causes. Bilateral renal zygomycosis should be suspected in any patient who presents with haematuria, flank pain and otherwise unexplained anuric renal failure. Characteristic CT findings and an early renal biopsy can confirm the diagnosis and help in effective management of this serious disease.  (+info)

Ichthyophonus irregularis sp. nov. from the yellowtail flounder Limanda ferruginea from the Nova Scotia shelf. (5/105)

A previously described unusual form of the protistan parasite Ichthyophonus, differing in morphological and developmental features from I. hoferi sensu Plehn & Mulsow, was recovered from yellowtail flounder Limanda ferruginea Storer from the Brown's Bank area of the Nova Scotia shelf. The nuclear gene encoding the rRNA of the small ribosomal subunit was amplified from this unusual form of Ichthyophonus using the polymerase chain reaction, sequenced and aligned with other eukaryote small subunit (ssu)-rDNAs. Inferred phylogenetic trees clearly show that its ssu-rDNA is distinct from those of 2 isolates of I. hoferi sensu Plehn & Mulsow from different hosts and geographical locations (herring in the North Sea, and yellowtail flounder from the Nova Scotia shelf). We consider the unusual form to be a separate species, I. irregularis. The occurrence of a second, distinct type of Ichthyophonus within a single host species raises the possibility that ichthyophoniasis could be produced by different (although related) pathogens, and in some cases, by concurrent infections of the two.  (+info)

Gastrointestinal basidiobolomycosis in Arizona: clinical and epidemiological characteristics and review of the literature. (6/105)

Gastrointestinal basidiobolomycosis (GIB) is an unusual fungal infection that is rarely reported in the medical literature. From April 1994 through May 1999, 7 cases of GIB occurred in Arizona, 4 from December 1998 through May 1999. We reviewed the clinical characteristics of the patients and conducted a case-control study to generate hypotheses about potential risk factors. All patients had histopathologic signs characteristic of basidiobolomycosis. Five patients were male (median age, 52 years; range, 37--59 years) and had a history of diabetes mellitus (in 3 patients), peptic ulcer disease (in 2), or pica (in 1). All patients underwent partial or complete surgical resection of the infected portions of their gastrointestinal tracts, and all received itraconazole postoperatively for a median of 10 months (range, 3--19 months). Potential risk factors included prior ranitidine use and longer residence in Arizona. GIB is a newly emerging infection that causes substantial morbidity and diagnostic confusion. Further studies are needed to better define its risk factors and treatment.  (+info)

Basidiobolus ranarum as an etiologic agent of gastrointestinal zygomycosis. (7/105)

Basidiobolus ranarum is a known cause of subcutaneous zygomycosis. Recently, its etiologic role in gastrointestinal infections has been increasingly recognized. While the clinical presentation of the subcutaneous disease is quite characteristic and the disease is easy to diagnose, gastrointestinal basidiobolomycosis poses diagnostic difficulties; its clinical presentation is nonspecific, there are no identifiable risk factors, and all age groups are susceptible. The case of gastrointestinal basidiobolomycosis described in the present report occurred in a 41-year-old Indian male who had a history of repair of a left inguinal hernia 2 years earlier and who is native to the southern part of India, where the subcutaneous form of the disease is indigenous. Diagnosis is based on the isolation of B. ranarum from cultures of urine and demonstration of broad, sparsely septate hyphal elements in histopathologic sections of the colon, with characteristic eosinophilic infiltration and the Splendore-Hoeppli phenomenon. The titers of both immunoglobulin G (IgG) and IgM antibodies to locally produced antigen of the fungus were elevated. The patient failed to respond to 8 weeks of amphotericin B therapy, and the isolate was later found to be resistant to amphotericin B, itraconazole, fluconazole, and flucytosine but susceptible to ketoconazole and miconazole. One other noteworthy feature of the fungus was that the patient's serum showed raised levels of Th2-type cytokines (interleukins 4 and 10) and tumor necrosis factor alpha. The present report underscores the need to consider gastrointestinal basidiobolomycosis in the differential diagnosis of inflammatory bowel diseases and suggests that, perhaps, more time should be invested in developing standardized serologic reagents that can be used as part of a less invasive means of diagnosis of the disease.  (+info)

Entomophthoramycosis by Conidiobolus coronatus. Report of a case successfully treated with the combination of itraconazole and fluconazole. (8/105)

Rhinoentomophthoramycosis caused by Conidiobolus coronatus in a 61-year old woman was unsuccessfully treated during 8 years with all the antifungals available in the Brazilian market, including potassium iodide for 1 month, sulfamethoxazole plus trimethoprim for 2 months, amphotericin B, total dose of 1130 mg, cetoconazole, 400 mg/day for 6 months, fluconazole, 200 mg/day, for at least 2 months and, itraconazole, 400 mg/day for 2 months, followed by 200 mg/day for 4 more months. Complete clinical and mycological cure was achieved using itraconazol 400 mg/day in association with fluconazol 200 mg/day during 24 months. After cure she was submitted to plastic surgery to repair her facial deformation. Today she remains clinically and mycologically cured after 59/60 months (5 years!) without any specific antifungal. We thus suggest the use of the combination of itraconazole and fluconazole as an additional option for the treatment of this mycosis.  (+info)

Zygomycosis is a rare, but serious fungal infection caused by filamentous fungi of the class Zygomycetes. These fungi are commonly found in the environment, particularly in soil and decaying organic matter. The infection primarily affects individuals with weakened immune systems, such as those with uncontrolled diabetes, HIV/AIDS, or those receiving immunosuppressive therapy.

Zygomycosis can manifest in various forms depending on the site of infection. The two main types are rhinocerebral zygomycosis (affecting the sinuses and brain) and pulmonary zygomycosis (affecting the lungs). Other forms include cutaneous (skin), gastrointestinal, and disseminated zygomycosis. Symptoms can range from mild to severe and may include fever, cough, shortness of breath, sinus pain or congestion, skin lesions, and neurological symptoms like headache, altered mental status, or vision changes.

Early diagnosis and prompt treatment with antifungal medications and surgical debridement are crucial for managing zygomycosis. The prognosis depends on the patient's underlying health condition and the extent of infection at the time of diagnosis.

Mucormycosis is a serious and often life-threatening invasive fungal infection caused by the Mucorales family of fungi. It primarily affects people with weakened immune systems, such as those with uncontrolled diabetes, cancer, organ transplant recipients, or those who have been treated with high doses of corticosteroids.

The infection typically begins in the respiratory tract after inhaling spores from the environment, but it can also occur through skin wounds or gastrointestinal exposure to the fungi. The infection can quickly spread to other parts of the body, including the sinuses, brain, and lungs, causing tissue damage and necrosis.

Symptoms of mucormycosis depend on the site of infection but may include fever, cough, shortness of breath, chest pain, headache, sinus congestion, facial swelling, and blackened areas of skin or tissue. Treatment typically involves a combination of antifungal medications, surgical debridement of infected tissue, and management of underlying medical conditions that increase the risk of infection.

Rhizopus is a genus of saprophytic fungi that belong to the family Mucoraceae. These fungi are commonly found in soil, decaying vegetation, and fruits. They are characterized by the presence of rhizoids, which are multicellular filaments that anchor the fungus to its substrate.

Rhizopus species are known to produce spores in large numbers, which can be dispersed through the air and cause infections in humans, particularly in individuals with weakened immune systems. One of the most common diseases caused by Rhizopus is mucormycosis, a serious and often life-threatening fungal infection that can affect various organs, including the sinuses, lungs, brain, and skin.

It's worth noting that while Rhizopus species are important pathogens in certain populations, they also have beneficial uses. For example, some species of Rhizopus are used in the production of tempeh, a traditional Indonesian food made from fermented soybeans.

Mucorales is a order of fungi that includes several genera of mold-like fungi, such as Mucor, Rhizopus, and Absidia. These fungi are commonly found in soil, decaying vegetation, and animal manure. Some species can cause mucormycosis, a serious and often life-threatening invasive fungal infection that primarily affects people with weakened immune systems, such as those with uncontrolled diabetes, cancer, or organ transplants. The infection typically begins in the respiratory tract, but it can spread to other parts of the body, including the sinuses, brain, and lungs. Mucormycosis is difficult to diagnose and treat, and it has a high mortality rate.

'Absidia' is a genus of filamentous fungi that belongs to the family Lasiosphaeriaceae. This genus includes several species of saprophytic molds that are commonly found in soil and decaying organic matter. Some species of Absidia can produce potentially harmful metabolites called trichothecenes, which can have toxic effects on humans and animals. However, it is important to note that exposure to this type of fungi is generally not considered a significant health concern for most people under normal circumstances.

Rhizomucor is a genus of fungi in the family Mucoraceae. It includes several species that are commonly found in soil, decaying organic matter, and air. Some species of Rhizomucor can cause mucormycosis, a serious and potentially life-threatening invasive fungal infection that primarily affects people with weakened immune systems.

Mucormycosis caused by Rhizomucor species often involves the sinuses, brain, and lungs, and can also spread to other parts of the body through the bloodstream. Symptoms may include fever, cough, shortness of breath, headache, nasal congestion, and black lesions on the skin. Treatment typically involves a combination of antifungal medications, surgical debridement, and management of underlying medical conditions that increase the risk of infection.

It's worth noting that mucormycosis is a rare but serious infection, and prompt diagnosis and treatment are essential for improving outcomes. Preventive measures such as avoiding contact with contaminated soil or water, wearing protective masks in dusty environments, and maintaining good hygiene can help reduce the risk of infection.

Dermatomycoses are a group of fungal infections that affect the skin, hair, and nails. These infections are caused by various types of fungi, including dermatophytes, yeasts, and molds. Dermatophyte infections, also known as tinea, are the most common type of dermatomycoses and can affect different areas of the body, such as the scalp (tinea capitis), beard (tinea barbae), body (tinea corporis), feet (tinea pedis or athlete's foot), hands (tinea manuum), and nails (tinea unguium or onychomycosis). Yeast infections, such as those caused by Candida albicans, can lead to conditions like candidal intertrigo, vulvovaginitis, and balanitis. Mold infections are less common but can cause skin disorders like scalded skin syndrome and phaeohyphomycosis. Dermatomycoses are typically treated with topical or oral antifungal medications.

Entomophthorales is a order of fungi that are known for their ability to infect and kill insects and other small arthropods. The name "Entomophthorales" comes from the Greek words "entomon," meaning insect, and "phthora," meaning destruction.

The fungi in this order typically infect their hosts by producing structures called appressoria, which help the fungus penetrate the host's cuticle. Once inside the host, the fungus grows and multiplies, eventually killing the host and releasing spores that can infect other insects or arthropods.

Entomophthorales includes several families of fungi, including Entomophthoraceae, Ancylistaceae, and Completoriaceae. Some species in this order are being studied for their potential as biological control agents for pest insects. However, it is important to note that some species in this order can also infect humans, although such infections are rare and usually only occur in people with weakened immune systems.

Nose diseases, also known as rhinologic disorders, refer to a wide range of conditions that affect the nose and its surrounding structures. These may include:

1. Nasal Allergies (Allergic Rhinitis): An inflammation of the inner lining of the nose caused by an allergic reaction to substances such as pollen, dust mites, or mold.

2. Sinusitis: Inflammation or infection of the sinuses, which are air-filled cavities in the skull that surround the nasal cavity.

3. Nasal Polyps: Soft, fleshy growths that develop on the lining of the nasal passages or sinuses.

4. Deviated Septum: A condition where the thin wall (septum) between the two nostrils is displaced to one side, causing difficulty breathing through the nose.

5. Rhinitis Medicamentosa: Nasal congestion caused by overuse of decongestant nasal sprays.

6. Nosebleeds (Epistaxis): Bleeding from the nostrils, which can be caused by a variety of factors including dryness, trauma, or underlying medical conditions.

7. Nasal Fractures: Breaks in the bone structure of the nose, often caused by trauma.

8. Tumors: Abnormal growths that can occur in the nasal passages or sinuses. These can be benign or malignant.

9. Choanal Atresia: A congenital condition where the back of the nasal passage is blocked, often by a thin membrane or bony partition.

10. Nasal Valve Collapse: A condition where the side walls of the nose collapse inward during breathing, causing difficulty breathing through the nose.

These are just a few examples of the many diseases that can affect the nose.

Conidiobolus is a genus of saprophytic fungi that belong to the order Entomophthorales. These fungi are known for producing conidia (asexual spores) on specialized structures called conidiophores. They are commonly found in soil, decaying plant material, and insects. While some species of Conidiobolus can cause mild infections in humans, they are generally not considered to be major pathogens.

"Mucor" is a genus of fungi that belongs to the order Mucorales. These fungi are commonly found in soil, decaying organic matter, and sometimes on fruits and vegetables. Some species of Mucor can cause mucormycosis, a rare but serious invasive fungal infection that primarily affects people with weakened immune systems, such as those with uncontrolled diabetes, cancer, organ transplant recipients, and those using high-dose corticosteroids.

Mucormycosis can affect various parts of the body, including the sinuses, lungs, skin, and gastrointestinal tract. The infection can quickly spread through the bloodstream and cause severe damage to tissues and organs. Early diagnosis and prompt treatment with antifungal medications and surgical debridement are crucial for managing mucormycosis and improving outcomes.

Orbital diseases refer to a group of medical conditions that affect the orbit, which is the bony cavity in the skull that contains the eye, muscles, nerves, fat, and blood vessels. These diseases can cause various symptoms such as eyelid swelling, protrusion or displacement of the eyeball, double vision, pain, and limited extraocular muscle movement.

Orbital diseases can be broadly classified into inflammatory, infectious, neoplastic (benign or malignant), vascular, traumatic, and congenital categories. Some examples of orbital diseases include:

* Orbital cellulitis: a bacterial or fungal infection that causes swelling and inflammation in the orbit
* Graves' disease: an autoimmune disorder that affects the thyroid gland and can cause protrusion of the eyeballs (exophthalmos)
* Orbital tumors: benign or malignant growths that develop in the orbit, such as optic nerve gliomas, lacrimal gland tumors, and lymphomas
* Carotid-cavernous fistulas: abnormal connections between the carotid artery and cavernous sinus, leading to pulsatile proptosis and other symptoms
* Orbital fractures: breaks in the bones surrounding the orbit, often caused by trauma
* Congenital anomalies: structural abnormalities present at birth, such as craniofacial syndromes or dermoid cysts.

Proper diagnosis and management of orbital diseases require a multidisciplinary approach involving ophthalmologists, neurologists, radiologists, and other specialists.

Amphotericin B is an antifungal medication used to treat serious and often life-threatening fungal infections. It works by binding to the ergosterol in the fungal cell membrane, creating pores that lead to the loss of essential cell components and ultimately cell death.

The medical definition of Amphotericin B is:

A polyene antifungal agent derived from Streptomyces nodosus, with a broad spectrum of activity against various fungi, including Candida, Aspergillus, Cryptococcus, and Histoplasma capsulatum. Amphotericin B is used to treat systemic fungal infections, such as histoplasmosis, cryptococcosis, candidiasis, and aspergillosis, among others. It may be administered intravenously or topically, depending on the formulation and the site of infection.

Adverse effects associated with Amphotericin B include infusion-related reactions (such as fever, chills, and hypotension), nephrotoxicity, electrolyte imbalances, and anemia. These side effects are often dose-dependent and may be managed through careful monitoring and adjustment of the dosing regimen.

Antifungal agents are a type of medication used to treat and prevent fungal infections. These agents work by targeting and disrupting the growth of fungi, which include yeasts, molds, and other types of fungi that can cause illness in humans.

There are several different classes of antifungal agents, including:

1. Azoles: These agents work by inhibiting the synthesis of ergosterol, a key component of fungal cell membranes. Examples of azole antifungals include fluconazole, itraconazole, and voriconazole.
2. Echinocandins: These agents target the fungal cell wall, disrupting its synthesis and leading to fungal cell death. Examples of echinocandins include caspofungin, micafungin, and anidulafungin.
3. Polyenes: These agents bind to ergosterol in the fungal cell membrane, creating pores that lead to fungal cell death. Examples of polyene antifungals include amphotericin B and nystatin.
4. Allylamines: These agents inhibit squalene epoxidase, a key enzyme in ergosterol synthesis. Examples of allylamine antifungals include terbinafine and naftifine.
5. Griseofulvin: This agent disrupts fungal cell division by binding to tubulin, a protein involved in fungal cell mitosis.

Antifungal agents can be administered topically, orally, or intravenously, depending on the severity and location of the infection. It is important to use antifungal agents only as directed by a healthcare professional, as misuse or overuse can lead to resistance and make treatment more difficult.

Paranasal sinus diseases refer to a group of medical conditions that affect the paranasal sinuses, which are air-filled cavities located within the skull near the nasal cavity. These sinuses include the maxillary, frontal, ethmoid, and sphenoid sinuses.

Paranasal sinus diseases can be caused by a variety of factors, including viral, bacterial, or fungal infections, allergies, structural abnormalities, or autoimmune disorders. Some common paranasal sinus diseases include:

1. Sinusitis: Inflammation or infection of the sinuses, which can cause symptoms such as nasal congestion, thick nasal discharge, facial pain or pressure, and reduced sense of smell.
2. Nasal polyps: Soft, benign growths that develop in the lining of the nasal passages or sinuses, which can obstruct airflow and cause difficulty breathing through the nose.
3. Sinonasal tumors: Abnormal growths that can be benign or malignant, which can cause symptoms such as nasal congestion, facial pain, and bleeding from the nose.
4. Sinus cysts: Fluid-filled sacs that form in the sinuses, which can cause symptoms similar to those of sinusitis.
5. Fungal sinusitis: Infection of the sinuses with fungi, which can cause symptoms such as nasal congestion, facial pain, and thick, discolored mucus.

Treatment for paranasal sinus diseases depends on the underlying cause and severity of the condition. Treatment options may include medications, such as antibiotics, antihistamines, or corticosteroids, as well as surgical intervention in more severe cases.

Fungal lung diseases, also known as fungal pneumonia or mycoses, refer to a group of respiratory disorders caused by the infection of fungi in the lungs. These fungi are commonly found in the environment, such as soil, decaying organic matter, and contaminated materials. People can develop lung diseases from fungi after inhaling spores or particles that contain fungi.

There are several types of fungal lung diseases, including:

1. Aspergillosis: This is caused by the Aspergillus fungus and can affect people with weakened immune systems. It can cause allergic reactions, lung infections, or invasive aspergillosis, which can spread to other organs.
2. Cryptococcosis: This is caused by the Cryptococcus fungus and is usually found in soil contaminated with bird droppings. It can cause pneumonia, meningitis, or skin lesions.
3. Histoplasmosis: This is caused by the Histoplasma capsulatum fungus and is commonly found in the Ohio and Mississippi River valleys. It can cause flu-like symptoms, lung infections, or disseminated histoplasmosis, which can spread to other organs.
4. Blastomycosis: This is caused by the Blastomyces dermatitidis fungus and is commonly found in the southeastern and south-central United States. It can cause pneumonia, skin lesions, or disseminated blastomycosis, which can spread to other organs.
5. Coccidioidomycosis: This is caused by the Coccidioides immitis fungus and is commonly found in the southwestern United States. It can cause flu-like symptoms, lung infections, or disseminated coccidioidomycosis, which can spread to other organs.

Fungal lung diseases can range from mild to severe, depending on the type of fungus and the person's immune system. Treatment may include antifungal medications, surgery, or supportive care. Prevention measures include avoiding exposure to contaminated soil or dust, wearing protective masks in high-risk areas, and promptly seeking medical attention if symptoms develop.

An immunocompromised host refers to an individual who has a weakened or impaired immune system, making them more susceptible to infections and decreased ability to fight off pathogens. This condition can be congenital (present at birth) or acquired (developed during one's lifetime).

Acquired immunocompromised states may result from various factors such as medical treatments (e.g., chemotherapy, radiation therapy, immunosuppressive drugs), infections (e.g., HIV/AIDS), chronic diseases (e.g., diabetes, malnutrition, liver disease), or aging.

Immunocompromised hosts are at a higher risk for developing severe and life-threatening infections due to their reduced immune response. Therefore, they require special consideration when it comes to prevention, diagnosis, and treatment of infectious diseases.

Fungi, in the context of medical definitions, are a group of eukaryotic organisms that include microorganisms such as yeasts and molds, as well as the more familiar mushrooms. The study of fungi is known as mycology.

Fungi can exist as unicellular organisms or as multicellular filamentous structures called hyphae. They are heterotrophs, which means they obtain their nutrients by decomposing organic matter or by living as parasites on other organisms. Some fungi can cause various diseases in humans, animals, and plants, known as mycoses. These infections range from superficial, localized skin infections to systemic, life-threatening invasive diseases.

Examples of fungal infections include athlete's foot (tinea pedis), ringworm (dermatophytosis), candidiasis (yeast infection), histoplasmosis, coccidioidomycosis, and aspergillosis. Fungal infections can be challenging to treat due to the limited number of antifungal drugs available and the potential for drug resistance.

Triazoles are a class of antifungal medications that have broad-spectrum activity against various fungi, including yeasts, molds, and dermatophytes. They work by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, leading to increased permeability and disruption of fungal growth. Triazoles are commonly used in both systemic and topical formulations for the treatment of various fungal infections, such as candidiasis, aspergillosis, cryptococcosis, and dermatophytoses. Some examples of triazole antifungals include fluconazole, itraconazole, voriconazole, and posaconazole.

'Entomophthora' is a genus of fungi that are known for their ability to infect and kill insects. These fungi are obligate parasites, meaning they can only complete their life cycle inside a living host. They are highly host-specific and have been reported to infect a wide range of insect species, including aphids, beetles, flies, and mosquitoes.

The infection process begins when the fungus releases spores that are dispersed by wind or water. When an insect comes into contact with these spores, they germinate and penetrate the insect's cuticle, eventually entering its body cavity. Once inside the host, the fungus grows and multiplies, producing toxins that can cause paralysis and other symptoms.

Eventually, the fungus produces a large number of spores within the insect's body, which are released when the infected insect dies and decomposes. These spores can then infect other nearby insects, continuing the life cycle of the fungus.

Entomophthora species have been studied as potential biological control agents for pest insects, as they can help to reduce populations without the use of chemical pesticides. However, more research is needed to fully understand their ecology and potential impacts on non-target organisms before they can be widely used in this way.

A ribosome is a complex molecular machine found in all living cells, responsible for protein synthesis. It consists of two subunits: the small and the large subunit. The small ribosomal subunit plays a crucial role in decoding the messenger RNA (mRNA) molecule and positioning transfer RNA (tRNA) molecules during translation.

The small ribosomal subunit, specifically, is composed of ribosomal RNA (rRNA) and proteins. In eukaryotic cells, the small ribosomal subunit is composed of a 18S rRNA molecule and approximately 30 distinct proteins. Its primary function is to recognize the start codon on the mRNA and facilitate the binding of the initiator tRNA (tRNAi) to begin the translation process.

Together, the small and large ribosomal subunits form a functional ribosome that translates genetic information from mRNA into proteins, contributing to the maintenance and growth of cells.

Pulmonary aspergillosis is a respiratory infection caused by the fungus Aspergillus. It mainly affects the lungs, but it can also spread to other parts of the body. There are several forms of pulmonary aspergillosis, including:

1. Allergic bronchopulmonary aspergillosis (ABPA): This form occurs in people with asthma or cystic fibrosis. The immune system overreacts to the presence of Aspergillus, causing inflammation and damage to the airways.
2. Aspergilloma: Also known as a fungus ball, this is a growth of Aspergillus that develops in a preexisting lung cavity, usually caused by old tuberculosis or scarring from previous lung infections.
3. Invasive pulmonary aspergillosis (IPA): This is the most severe form and occurs when the fungus invades the lung tissue, blood vessels, and other organs. It primarily affects people with weakened immune systems due to conditions like cancer, HIV/AIDS, organ transplants, or long-term use of corticosteroids.

Symptoms of pulmonary aspergillosis can vary depending on the form and severity of the infection. They may include cough, chest pain, shortness of breath, fever, fatigue, weight loss, and bloody sputum. Diagnosis typically involves imaging tests like chest X-rays or CT scans, along with laboratory tests to detect Aspergillus antigens or DNA in blood or respiratory samples. Treatment options include antifungal medications, surgery to remove fungal growths, and management of underlying conditions that weaken the immune system.

Diabetic ketoacidosis (DKA) is a serious metabolic complication characterized by the triad of hyperglycemia, metabolic acidosis, and increased ketone bodies. It primarily occurs in individuals with diabetes mellitus type 1, but it can also be seen in some people with diabetes mellitus type 2, particularly during severe illness or surgery.

The condition arises when there is a significant lack of insulin in the body, which impairs the ability of cells to take up glucose for energy production. As a result, the body starts breaking down fatty acids to produce energy, leading to an increase in ketone bodies (acetoacetate, beta-hydroxybutyrate, and acetone) in the bloodstream. This process is called ketosis.

In DKA, the excessive production of ketone bodies results in metabolic acidosis, which is characterized by a lower than normal pH level in the blood (< 7.35) and an elevated serum bicarbonate level (< 18 mEq/L). The hyperglycemia in DKA is due to both increased glucose production and decreased glucose utilization by cells, which can lead to severe dehydration and electrolyte imbalances.

Symptoms of diabetic ketoacidosis include excessive thirst, frequent urination, nausea, vomiting, abdominal pain, fatigue, fruity breath odor, and altered mental status. If left untreated, DKA can progress to coma and even lead to death. Treatment typically involves administering insulin, fluid replacement, and electrolyte management in a hospital setting.

'Cunninghamella' is a genus of fungi that belongs to the family of Mucoraceae. These saprophytic fungi are commonly found in soil, decaying vegetation, and animal feces. They are known for their ability to produce various enzymes and metabolites, which can be useful in biotechnological applications. However, some species of Cunninghamella can also cause opportunistic infections in humans, particularly in immunocompromised individuals.

Opportunistic infections (OIs) are infections that occur more frequently or are more severe in individuals with weakened immune systems, often due to a underlying condition such as HIV/AIDS, cancer, or organ transplantation. These infections are caused by microorganisms that do not normally cause disease in people with healthy immune function, but can take advantage of an opportunity to infect and cause damage when the body's defense mechanisms are compromised. Examples of opportunistic infections include Pneumocystis pneumonia, tuberculosis, candidiasis (thrush), and cytomegalovirus infection. Preventive measures, such as antimicrobial medications and vaccinations, play a crucial role in reducing the risk of opportunistic infections in individuals with weakened immune systems.

... is the broadest term to refer to infections caused by bread mold fungi of the zygomycota phylum. However, because ... Zygomycosis has been found in survivors of the 2004 Indian Ocean earthquake and tsunami and in survivors of the 2011 Joplin, ... Zygomycosis type infections are most often caused by common fungi found in soil and decaying vegetation. While most individuals ... Pathogenic zygomycosis is caused by species in two orders: Mucorales or Entomophthorales, with the former causing far more ...
Zygomycosis usually is a disease of the skin, but can also occur in the sinuses or gastrointestinal tract. In humans it is most ... Zygomycosis of the sinuses can extend from the sinuses into the orbit and the cranial vault, leading to rhinocerebral ... Zygomycosis can also be caused by two types of zygomycetes, Entomophthorales (such as Basidiobolus and Conidiobolus) and ... Zygomycosis caused by Mucorales causes a rapidly progressing disease of sudden onset in sick or immunocompromised animals. ...
"Mucormycosis (Zygomycosis) Differential Diagnoses". emedicine.medscape.com. Retrieved May 25, 2021. BNF (80 ed.). BMJ Group and ... "Mucormycosis (Zygomycosis) Clinical Presentation: History and Physical Examination". emedicine.medscape.com. Retrieved May 28, ... ISBN 978-93-86261-83-0. "Orphanet: Zygomycosis". www.orpha.net. Archived from the original on May 13, 2021. Retrieved May 13, ... "Mucormycosis (Zygomycosis) Workup: Approach Considerations, Laboratory Tests, Radiologic Studies". emedicine.medscape.com. ...
... and zygomycosis". Clin. Chest Med. 30 (2): 337-53, vii-viii. doi:10.1016/j.ccm.2009.02.009. PMID 19375639. James, William D.; ...
Lawrence, R.M.; Snodgrass, W.T.; Reichel, G.W.; Padhye, A.A.; Ajello, L.; Chandler, F.W. (1986). "Systemic zygomycosis caused ... Unlike other zygomycosis, the affected host is usually otherwise immunocompetent. Apophysomyces elegans infections present most ... Fungi portal Mucormycosis (specific term for infection caused by fungi of the order Mucorales) Zygomycosis (a more generic term ... Cooter, RD; Lim, IS; Ellis, DH; Leitch, IO (1990). "Burn wound zygomycosis caused by Apophysomyces elegans". Journal of ...
ISBN 978-93-86261-83-0. Naggie S, Perfect JR (June 2009). "Molds: hyalohyphomycosis, phaeohyphomycosis, and zygomycosis". Clin ...
HILL, BD; BLACK, PF; KELLY, M; MUIR, D; DONALD, WAJ MC (1 July 1992). "Bovine cranial zygomycosis caused by Saksenaea ... Pritchard, RC; Muir, DB; Archer, KH; Beith, JM (1-15 Dec 1986). "Subcutaneous zygomycosis due to Saksenaea vasiformis in an ... Bearer, EA; Nelson, PR; Chowers, MY; Davis, CE (July 1994). "Cutaneous zygomycosis caused by Saksenaea vasiformis in a diabetic ... Lye, GR; Wood, G; Nimmo, G (November 1996). "Subcutaneous zygomycosis due to Saksenaea vasiformis: rapid isolate identification ...
... and zygomycosis in small animals". Vet Clin North Am Small Anim Pract. 33 (4): 695-720, v. doi:10.1016/S0195-5616(03)00034-2. ...
Grooters A (2003). "Pythiosis, lagenidiosis, and zygomycosis in small animals". Vet Clin North Am Small Anim Pract. 33 (4): 695 ...
Grooters A (2003). "Pythiosis, lagenidiosis, and zygomycosis in small animals". Vet Clin North Am Small Anim Pract. 33 (4): 695 ...
Honda, A.; Kamei, K.; Unno, H.; Hiroshima, K.; Kuriyama, T.; Miyaji, M. (1998). "A murine model of zygomycosis by ... Infections with this fungus are classified as opportunistic zygomycoses or mucormycoses, and risk factors for infection are ...
Subcutaneous zygomycosis caused by B. ranarum is a rare disease and predominantly affects children and males. Common ... reported and described the first four cases of zygomycosis in Indonesia. Since then, hundreds of the cases of this infection ... Basidiobolus ranarum is also known as a cause of subcutaneous zygomycosis, usually causing granulomatous infections on a host's ... Considering the broad-range distribution of B. ranarum and its high ubiquity, subcutaneous zygomycosis is not really prevalent ...
She had inhaled mold in the studio, contracting zygomycosis. Back in House's office, Cuddy thanks House for the injections. ...
Rhizomucor pusillis can lead to zygomycosis in humans. It causes necrosis of infected tissues and pen neural invasion. It is an ... "Molecular identification of Rhizomucor pusillus as a cause of sinus-orbital zygomycosis in a patient with acute myelogenous ...
"Lecture 9 - Opportunistic mycoses I: Aspergillosis, Sporotrichosis, Zygomycosis & Rhinosporidiosis" (PDF). Archived from the ...
... is the causative fungal agent of chronic rhinofacial zygomycosis. Chronic rhinofacial zygomycosis is a ... Rhinofacial zygomycosis caused by C. coronatus has been reported in humans, horses, dolphins, chimpanzees and other animals. In ... The rhinofacial zygomycosis pattern of infection can manifest when C. coronatus spores enter the nasal cavities through ... The vast majority of human cases of rhino facial zygomycosis caused by C. coronatus have occurred in central and west Africa, ...
"Primary cutaneous zygomycosis from a tertiary care centre in north-west India". The Indian Journal of Medical Research. 131: ...
February 2010). "Forty-one recent cases of invasive zygomycosis from a global clinical registry". The Journal of Antimicrobial ...
"Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases". Clin Infect Dis. 42 (7): e61 ...
It is especially useful for the identification of Mucor and the causative agents of zygomycosis. Calcofluor-white can be used ...
... and Zygomycosis. These diseases may be transmitted to humans through excreted waste, open wounds, and contaminated water. A ...
There have also been rare case reports of paracoccidioidomycosis, zygomycosis and histoplasmosis infections causing genital ...
... necrotizing infections known as Zygomycosis. M. amphibiorum M. circinelloides M. ellipsoideus M. fragilis M. hiemalis M. ...
Also referred to as zygomycosis, this necrotizing infection can be life threatening in diabetic or immuno-suppressed/ ...
... preferred treatment for lymphocutaneous sporotrichosis and subcutaneous zygomycosis (basidiobolomycosis). The mode of action is ...
Mucormycosis is a collection of fungal and mold diseases in dogs including pythiosis, zygomycosis, and lagenidiosis that affect ...
April 2005). "Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control ...
"An increasing trend of cutaneous zygomycosis caused by Mycocladus corymbifer(formerly Absidia corymbifera): report of two cases ...
Diseases caused by funguses include candidiasis cryptococcosis facial eczema fungal placentitis sporotrichosis zygomycosis ...
White piedra White superficial onychomycosis Zygomycosis (phycomycosis) Parasitic infestations, stings, and bites in humans are ...
Zygomycosis is the broadest term to refer to infections caused by bread mold fungi of the zygomycota phylum. However, because ... Zygomycosis has been found in survivors of the 2004 Indian Ocean earthquake and tsunami and in survivors of the 2011 Joplin, ... Zygomycosis type infections are most often caused by common fungi found in soil and decaying vegetation. While most individuals ... Pathogenic zygomycosis is caused by species in two orders: Mucorales or Entomophthorales, with the former causing far more ...
encoded search term (Mucormycosis (Zygomycosis)) and Mucormycosis (Zygomycosis) What to Read Next on Medscape ... Mucormycosis (Zygomycosis). Updated: Jul 06, 2021 * Author: Avnish Sandhu, DO; Chief Editor: Pranatharthi Haran Chandrasekar, ... Impact of zygomycosis on microbiology workload: a survey study in Spain. J Clin Microbiol. 2007 Jun. 45 (6):2051-3. [QxMD ... Mucormycosis, previously called zygomycosis, refers to several different diseases caused by infection with fungi belonging to ...
encoded search term (Mucormycosis (Zygomycosis)) and Mucormycosis (Zygomycosis) What to Read Next on Medscape ... Mucormycosis (Zygomycosis) Medication. Updated: Jul 06, 2021 * Author: Avnish Sandhu, DO; Chief Editor: Pranatharthi Haran ... Impact of zygomycosis on microbiology workload: a survey study in Spain. J Clin Microbiol. 2007 Jun. 45 (6):2051-3. [QxMD ... Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005 Sep 1. 41 (5):634-53. [QxMD ...
Increased Incidence of Zygomycosis in Metropolitan France. Figure 1. Figure 1. Evolution of the incidence of zygomycosis, ... Kontoyiannis DP, Lionakis MS, Lewis RE, Chamilos G, Healy M, Perego C, Zygomycosis in a tertiary-care cancer center in the era ... Greenberg RN, Mullane K, van Burik JA, Raad I, Abzug MJ, Anstead G, Posaconazole as salvage therapy for zygomycosis. Antimicrob ... Chakrabarti A, Das A, Mandal J, Shivaprakash MR, George VK, Tarai B, The rising trend of invasive zygomycosis in patients with ...
Zygomycosis. Synonyms: Mucormycosis. A rare mycosis caused by ubiquitous opportunistic fungi of the order Mucorales ... Zygomycosis?. Our RARE Concierge Services Guides are available to assist you by providing information, resources and ...
zygomycosis/demonstrate lesions in the liver,spleen,kidney,pancreas,stomach and omentum http://www.emedicine.com/med/topic2438. ... zygomycosis By Guest guest, January 8, 2008. in Health, Medicine and Natural Healing 08 ...
Zygomycosis). How to Say It: MU-kor-mi-ko-sis. by Amy Scholten, MPH ...
Mucormycosis (Zygomycosis). N. *Naegleria fowleri (Naegleria Infection). *National Antimicrobial Resistance Monitoring System ...
England, A. C., Weinstein, M., Ellner, J. J., & Ajello, L. (1981). Two cases of rhinocerebral zygomycosis (Mucormycosis) with ... England AC, Weinstein M, Ellner JJ, Ajello L. Two cases of rhinocerebral zygomycosis (Mucormycosis) with common epidemiologic ... England, AC, Weinstein, M, Ellner, JJ & Ajello, L 1981, Two cases of rhinocerebral zygomycosis (Mucormycosis) with common ... Two cases of rhinocerebral zygomycosis (Mucormycosis) with common epidemiologic and environmental features. / England, A. C.; ...
Gastrointestinal zygomycosis due to Rhizopus microsporus var. rhizopodiformis as a manifestation of chronic granulomatous ... A case of gastrointestinal zygomycosis in a 10-month-old boy with chronic granulomatous disease (CGD) is presented. Zygomycetes ... are an uncommon cause of fungal disease in CGD patients and gastrointestinal zygomycosis has not been previously described in ...
Mucormycosis/Zygomycosis • Rhinocerebral mucormycosis • Infections in diabetics, the elevated glucose enriches fungal growth • ... MUCORMYCOSIS/ ZYGOMYCOSIS Fungi in the Order Mucorales Hyaline Broad hyphae without septations ...
However, zygomycosis has also been reported in individuals without known risk factors. Zygomycosis can present clinically as ... In a review on current and future treatments of zygomycosis, Rogers (2008) noted that zygomycosis is a frequently lethal ... Treatment of zygomycosis: Current and new options. J Antimicrob Chemother. 2008;61 Suppl 1:i35-i40. ... Studies of salvage therapy of zygomycosis with posaconazole have yielded promising results and there are additional case ...
Zygomycosis. Mucor and Rhizopus species are the most common agents to cause zygomycosis. [36] Fungi of the order Mucorales (of ... Rhinocerebral zygomycosis is usually caused by Rhizopus oryzae or Rhizopus arrhizus. This condition has been reported in ... Classic zygomycosis occurs worldwide. In some warmer regions, other Zygomycetes such as Conidiobolus coronatus infect a range ... Bonifaz A, Macias B, Paredes-Farrera F, Arias P, Ponce RM, Araiza J. Palatal zygomycosis: experience of 21 cases. Oral Dis. ...
Cutaneous zygomycosis. Bonifaz A, Vázquez-González D, Tirado-Sánchez A, Ponce-Olivera RM. Bonifaz A, et al. Among authors: ...
Cutaneous zygomycosis: a poor prognostic indicator in burns patients. Cutaneous zygomycosis: a poor prognostic indicator in ...
keywords = "zygomycosis, zygomycosis",. author = "A Skiada and Livio Pagano and A Groll and S Zimmerli and B Dupont and K ... Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) ... Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) ... Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) ...
Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) ... Almyroudis NG, Sutton DA, Linden P, Rinaldi MG, Fung J, Kusne S. Zygomycosis in solid organ transplant recipients in a tertiary ... Pulmonary Mucormycosis (Zygomycosis) Presenting as an Infective Exacerbation of Chronic Obstructive Pulmonary Disease ... Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis 2005;42:634-653. ...
Ibrahim A, Edwards J, Filler S. Zygomycoses. In: Dismukes WE, Pappas PG, Sobel JD, eds. Clinical Mycology. New York, NY: Oxford ...
Zygomycosis in a tertiary-care center in the era of Aspergillus-active antifungal therapy: a case-control observational study ...
Rhinocerebral zygomycosis in a sheep. Can. Vet. J. 42(3):227-228. ,PMid:11265195,, Riet-Correa 2007Riet-Correa F. 2007. ... Rhinocerebral zygomycosis in a sheep. Can. Vet. J. 42(3):227-228. ,PMid:11265195,). Sheep display two clinical forms of the ... Rhinocerebral zygomycosis in a sheep. Can. Vet. J. 42(3):227-228. ,PMid:11265195,), fibrovascular tissue, lymphocytic ... Outbreaks of rhinofacial and rhinopharyngeal zygomycosis in sheep in Paraíba, northeastern Brazil. Pesq. Vet. Bras. 28(1):29-35 ...
The working group in zygomycosis of the European confederation of medical mycology (ECMM) prospectively collected cases of ... patients with zygomycosis, 130 patients received liposomal amphotericin B (L-AMB) as first-line therapy, either alone (68) or ...
Categories: Zygomycosis Image Types: Photo, Illustrations, Video, Color, Black&White, PublicDomain, CopyrightRestricted 57 ...
Indication: Zygomycosis Amphotericin B Indication: Zygomycosis Anti-Thymocyte Globulin NOS Indication: Prophylaxis Against ... Indication: Zygomycosis Fluconazole Indication: Antifungal Prophylaxis Busulfan Indication: Stem Cell Transplant Methotrexate ... Reactions: Liver Injury, Zygomycosis, Pneumothorax, Pleural Effusion, Febrile Neutropenia, Thrombocytopenia Adverse event ...
Zygomycosis. How long have you been taking it?. Choose one *Less than a week ...
Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis 41: 634-653. ... Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis 41: 634-653. ... Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis 41: 634-653. ... Epidemiology and outcome of zygomycosis: a review of 929 reported cases. . Clin Infect Dis 41. : 634. -. 653. .. ), false ...
Rhinocerebral zygomycosis : a clinicopathological study.. Sundaram C, Sundram C. Year : 1998, Volume: 46, Issue : 2 , Page no: ...
Emerging zygomycoses of humans: Saksenaea vasiformis and Apophysomyces elegans. Curr Top Med Mycol. 8:27-34. ...
The ensuing infection, known as mucormycosis or zygomycosis, spreads rapidly from the nose and sinuses to the face, jaw, eyes, ...
Zygomycosis is caused by what CLASS of fungi?. = Infection of nasal cavity and orbit, causing tissue necrosis. Think Zygomatic ...

No FAQ available that match "zygomycosis"

No images available that match "zygomycosis"